Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2003
12/11/2003WO2002061108A3 Microorganisms and processes for enhanced production of pantothenate
12/11/2003WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/11/2003US20030229925 Recombinant lactoferrins, methods of production from plants and uses thereof
12/11/2003US20030229923 Nucleic acid molecules encoding alternansucrase
12/11/2003US20030229921 Microbial beta-glucuronidase genes, gene products and uses thereof
12/11/2003US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides
12/11/2003US20030229210 Process for the preparation of active somatotropin from inclusion bodies
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229205 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films
12/11/2003US20030229204 PCG-1, a novel brown fat PPARgamma coactivator
12/11/2003US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers
12/11/2003US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants
12/11/2003US20030229046 Genetic engineering; polynucleotides; translation of codon of human cytomegalo virus
12/11/2003US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228995 Multiply-substituted protease variants with altered net charge for use in detergents
12/11/2003US20030228684 Photobioreactor
12/11/2003US20030228680 Nutrient broth for producing milk, meat, vegetable and beverage based products
12/11/2003US20030228678 Alleles of the aceA gene from coryneform bacteria
12/11/2003US20030228676 Comprises nucleotide sequences coding proteolytic enzyme asociated with aggrecan degradation for treating degenerative joint diseases
12/11/2003US20030228672 Comprises nucleotide sequences coding oxidoreductases for transformation and fermentive production of 2-keto-L-gulonic acid
12/11/2003US20030228671 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production
12/11/2003US20030228670 Synthetic enzymes for the production of coniferyl alcohol, coniferylaldehyde, ferulic acid, vanillin and vanillic acid and their use
12/11/2003US20030228669 Contain the genes required for polyhydroxyalkanoate formation integrated on the chromosome
12/11/2003US20030228668 Fatty acyl-CoA: fatty alcohol acyltransferases
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228657 Methods for enhancing the translation and expression of recombinant proteins
12/11/2003US20030228654 Method for producing antimicrobial protein and fusion protein
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228649 Polypeptides for identifying fungicidally active compounds
12/11/2003US20030228633 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function
12/11/2003US20030228623 For rapid production of diverse populations of selectable compounds as well as ready selection from such populations of small molecules attached to display peptides that bind target molecules or have desired activities (e.g. antibiotics); drugs
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228589 Incubating the composition containing a target nucleic acid template, a primer, an extendable nucleotide, and thermus thermophilus GK24 and thermus oshimai(G43D, F665Y) under appropriate conditions to generate primer extension product
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/11/2003US20030228569 Methods and compositions for high yield production of eukaryotic proteins
12/11/2003US20030228328 Vaccine for periodontal disease
12/11/2003US20030228323 Protein vaccine; culture product; genetic engineering
12/11/2003US20030228319 Antitumor agents, anticancer agents
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228297 Lactobacilli expressing biologically active polypeptides and uses thereof
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488441A1 Synthetic antibody phage libraries
12/11/2003CA2488281A1 Novel bacterium for treatment of disease
12/11/2003CA2488264A1 Streptococcus thermophilus strain producing exopolysaccharide
12/11/2003CA2488196A1 Methods and materials for the production of lactic acid in yeast
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487296A1 Methods and materials for the production of d-lactic acid in yeast
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/11/2003CA2486616A1 Methods, compositions and kits for cell separation
12/11/2003CA2485653A1 Human 5-ht7 receptor promoter sequence
12/11/2003CA2485513A1 Modified phytases
12/11/2003CA2485306A1 Synthesis of cis-diols from aryl silanes
12/11/2003CA2485203A1 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
12/10/2003EP1369488A1 Medium for the fermentive production of 1,3-propanediol, process and microorganism
12/10/2003EP1369486A1 Plasmid shuttle vector between escherichia coli and brevibacillus
12/10/2003EP1369485A1 Glucose dehydrogenase
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369481A1 Novel translational activity-promoting higher-order structure
12/10/2003EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte
12/10/2003EP1369476A1 A novel protein, a gene encoding therefor and a method of using the same
12/10/2003EP1369475A1 Microbiological process for enantioselective (S)-hydroxylation
12/10/2003EP1369474A1 Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
12/10/2003EP1369431A1 Anti-hla-dr antibody
12/10/2003EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR
12/10/2003EP1368485A2 Process for the preparation of d-pantothenic acid and/or salts thereof
12/10/2003EP1368482A2 Nitrile hydratase and a method for producing amides
12/10/2003EP1368481A2 Characterization of the i-spoml endonuclease from fission yeast
12/10/2003EP1368480A2 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii
12/10/2003EP1368475A1 Novel nucleic acids and polypeptides
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368471A2 Compositions and methods relating to prostate specific genes and proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368463A2 Biological compositions for solid waste treatment
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
12/10/2003EP0996735B1 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0934402B1 High molecular weight trichoderma cellulase
12/10/2003EP0770139B1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE
12/10/2003EP0724641B1 Anti-microbial proteins
12/10/2003EP0674714B1 Recombinant canine gastric lipase and pharmaceutical compositions
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0649472B1 Fusion proteins comprising eukaryotic cytochrome p450 fused to a reductase
12/10/2003EP0646177B1 HETEROLOGOUS GENE EXPRESSION IN $i(BACILLUS SUBTILIS): FUSION APPROACH
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 1489